Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEMSAV: Gadobutrol-Enhanced MRA in Supra-aortic Vascular Disease
NCT01344447Phase 3Completed
- Sponsor
- Bayer
- Start
- May 2011
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of gadobutrol in supra-aortic trunk atherosclerosis, sponsored by Bayer. Started May 2011; status: completed.
02
Drugs
gadobutrol
03
Conditions
supra-aortic trunk atherosclerosis
Beyond the preview
Go deeper on NCT01344447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01344447.